Combination Therapy of Niraparib and Irinotecan in Cancers With Mutations in DNA Repair Genes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05694715

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:12.771309+00:00

Published At

2026-03-17T00:00:00+00:00

Record Updated At

2026-03-17

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Metastatic Solid Tumor", "BRCA1 Mutation", "BRCA2 Mutation", "ATM Gene Mutation", "PALB2 Gene Mutation"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-17"

protocolSection.identificationModule.nctId

"NCT05694715"

protocolSection.identificationModule.officialTitle

"Combination Therapy of Niraparib and Irinotecan in Cancers With Mutations in DNA Repair Genes"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Metastatic Solid Tumor (protocolSection.conditionsModule.conditions)
• BRCA1 Mutation (protocolSection.conditionsModule.conditions)
• BRCA2 Mutation (protocolSection.conditionsModule.conditions)
• ATM Gene Mutation (protocolSection.conditionsModule.conditions)
• PALB2 Gene Mutation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.